Načítá se...
ApoC-III: a potent modulator of hypertriglyceridemia and cardiovascular disease
PURPOSE OF REVIEW: To summarize the recent epidemiological, basic science, and pharmaceutical research linking apoC-III with the development and treatment of cardiovascular disease. RECENT FINDINGS: ApoC-III is an important emerging target linking hypertriglyceridemia with cardiovascular disease (CV...
Uloženo v:
| Vydáno v: | Curr Opin Endocrinol Diabetes Obes |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4524519/ https://ncbi.nlm.nih.gov/pubmed/25692924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MED.0000000000000136 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|